Warren Cook

Warren Cook is an experienced professional in the pharmaceutical industry, currently serving as Therapy Area Lead at Alexion Pharmaceuticals, Inc. since January 2022, where leadership of the international therapeutic area team for NF1 is a primary focus. Previously, Cook held roles at AstraZeneca as Commercial Lead for Rare Diseases and engaged in various senior positions at Mundipharma International Limited, including Global Brand Director for Oncology Biosimilars, achieving significant milestones such as the successful launch of the first monoclonal antibody biosimilar in EU markets. Earlier roles at Astellas Pharma involved brand management in anti-infectives and dermatology, alongside foundational experience as a Medical Sales Representative at Yamanouchi and as a Senior Scientific Research Assistant at Zeneca Agrochemicals. Warren holds a Bachelor of Science in Applied Biology (Biotechnology) from Newcastle University and a CIM Postgraduate Diploma in Marketing from the University of West London.